Connect with:
Friday, December 15, 2017


PREDICT Model: Estimate Benefit of Systemic Therapy Following Breast Cancer Surgery

PREDICT is a mathematical model, accessed by the internet designed for patients and doctors to help them estimate the benefit of systemic endocrine, chemo- or anti-HER2 therapy following breast cancer surgery. It is the first model of this type to include tumor HER2 and KI67 status. It can be used in place of (currently non-functional) AdjuvantOnline.

Written by

<p>Breast Cancer Network Editorial Staff</p>

No comments

leave a comment

- Enter Your Location -
- or -